The quantification of immunohistochemical signals for 33 GBM samples revealed that 24 of the samples demonstrated positive staining for SPRR3 (72.7%) while only 11.1% of the normal tissue stained positively for SPRR3 (one in nine samples). Here, SPRR3 is linked to glioblastoma.